Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights ...
19d
New Study Establishes Vivio System as First Technology to Accurately Measure LVEDP Non-Invasively
Measurement – the Gold Standard for Heart Failure Diagnosis – Previously Only Obtainable Via Invasive Procedures PASADENA, Calif.--(BUSINESS WIRE)--#cardiology--Ventric Health, a medtech innovator ...
New technological developments in the cardiology field have increased collaboration to improve patient care, according to one cardiac surgeon. Frank Fazzalari, MD, who is the chief of cardiothoracic ...
Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million. Cardiac ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback